Systemic thrombolysis for acute, severe Budd-Chiari syndrome.
Budd-Chiari syndrome (BCS) or hepatic venous outflow obstruction, is a rare and complex clinical entity, with diverse aetiology and a wide range of presentations. Its rarity and heterogeneity create significant challenges for evidence-based clinical decision-making, particularly in the even more infrequent setting of acute BCS presentation. Here we present the case of a young woman with acute, severe BCS, where treatment alternatives were limited due to a significant IVC thrombus burden. A clearly defined acute onset allowed the prompt use of systemic thrombolysis, conducted in consultation with a multi-disciplinary team of clinicians, with close monitoring for both treatment response and complications. Her treatment resulted in resolution of hepatic vein occlusion and prevention of the potentially significant clinical sequelae. We review the literature and discuss current opinion in the management of BCS.
Duke Clinical Research Institute, Duke University, Durham, NC, 27715, USA. paul.j.clark@vq.edu.au
Paul J
PJ
Clark
Richard E
RE
Slaughter
Dorothy J
DJ
Radford
D000328:Adult; D006502:Budd-Chiari Syndrome / Q000000981:diagnostic imaging* / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D011859:Radiography; D015912:Thrombolytic Therapy / Q000379:methods*